PL4025192T3 - Sposób wytwarzania tabletki zawierającej peptydy glp-1 - Google Patents

Sposób wytwarzania tabletki zawierającej peptydy glp-1

Info

Publication number
PL4025192T3
PL4025192T3 PL20764666.2T PL20764666T PL4025192T3 PL 4025192 T3 PL4025192 T3 PL 4025192T3 PL 20764666 T PL20764666 T PL 20764666T PL 4025192 T3 PL4025192 T3 PL 4025192T3
Authority
PL
Poland
Prior art keywords
peptides
manufacturing
tablet containing
containing glp
glp
Prior art date
Application number
PL20764666.2T
Other languages
English (en)
Inventor
Pall Thor INGVARSSON
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of PL4025192T3 publication Critical patent/PL4025192T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL20764666.2T 2019-09-02 2020-09-02 Sposób wytwarzania tabletki zawierającej peptydy glp-1 PL4025192T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19194868 2019-09-02
PCT/EP2020/074426 WO2021043803A1 (en) 2019-09-02 2020-09-02 Process for producing a tablet comprising glp-1 peptides

Publications (1)

Publication Number Publication Date
PL4025192T3 true PL4025192T3 (pl) 2026-03-23

Family

ID=67840964

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20764666.2T PL4025192T3 (pl) 2019-09-02 2020-09-02 Sposób wytwarzania tabletki zawierającej peptydy glp-1

Country Status (11)

Country Link
US (1) US20220409701A1 (pl)
EP (1) EP4025192B1 (pl)
JP (1) JP7767264B2 (pl)
CN (1) CN114340655A (pl)
BR (1) BR112022002189A2 (pl)
ES (1) ES3058528T3 (pl)
HR (1) HRP20251672T1 (pl)
IL (1) IL290056B1 (pl)
PL (1) PL4025192T3 (pl)
RS (1) RS67632B1 (pl)
WO (1) WO2021043803A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102272671B1 (ko) 2013-05-02 2021-07-06 노보 노르디스크 에이/에스 Glp-1 화합물의 경구 투여
EP4370102A1 (en) * 2021-07-15 2024-05-22 Novo Nordisk A/S Tablet comprising a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
CN114984191B (zh) * 2022-07-04 2022-10-25 北京惠之衡生物科技有限公司 一种多肽类药物口服递送组合物
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy
WO2025133729A1 (en) 2023-12-18 2025-06-26 Assia Chemical Industries Ltd. Process for preparation of glp-1 peptides and dual glp-1/gip peptides having controlled particle size
CN118319871B (zh) * 2024-04-19 2025-08-05 鲁南新时代生物技术有限公司 一种司美格鲁肽药物组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI362392B (en) 2005-03-18 2012-04-21 Novo Nordisk As Acylated glp-1 compounds
JP5496082B2 (ja) * 2007-04-30 2014-05-21 ノボ・ノルデイスク・エー／エス タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
US20110144010A1 (en) 2007-06-01 2011-06-16 Novo Nordisk A/S Spontaneously Dispersible Preconcentrates Including a Peptide Drug in a Solid or Semisolid Carrier
JP5740689B2 (ja) 2008-08-18 2015-06-24 エンテラ バイオ エルティーディー． タンパク質の経口投与用の方法および組成物
US20100183876A1 (en) * 2008-12-23 2010-07-22 Hell Andre Process for the Preparation of a Peptide Powder Form
SI2651398T1 (en) * 2010-12-16 2018-04-30 Novo Nordisk A/S SOLID COMPOSITIONS CONTAINING GLP-1 AGONIST AND SOL N- (8- (2-HYDROXYBENZOIL) AMINO) CAPRICULATE ACIDS
PL2696687T3 (pl) * 2011-04-12 2017-06-30 Novo Nordisk A/S Pochodne podwójnie acylowanej GLP-1
HRP20181447T1 (hr) * 2012-03-22 2018-11-02 Novo Nordisk A/S Pripravci glp-1 peptida i njihova priprava
ES2965469T3 (es) 2012-03-22 2024-04-15 Novo Nordisk As Composiciones que comprenden un agente de suministro y preparación de estas
JP6517690B2 (ja) 2012-06-20 2019-05-22 ノヴォ ノルディスク アー／エス ペプチド及び送達剤を含む錠剤製剤
ES2741507T3 (es) * 2014-04-07 2020-02-11 Novo Nordisk As Compuestos de glp-1 acilados doblemente
JP6898518B2 (ja) 2018-02-02 2021-07-07 ノヴォ ノルディスク アー／エス Ｇｌｐ−１アゴニスト、ｎ−（８−（２−ヒドロキシベンゾイル）アミノ）カプリル酸の塩及び滑沢剤を含む固形組成物

Also Published As

Publication number Publication date
HRP20251672T1 (hr) 2026-02-13
IL290056A (en) 2022-03-01
WO2021043803A1 (en) 2021-03-11
ES3058528T3 (en) 2026-03-11
BR112022002189A2 (pt) 2022-04-26
EP4025192A1 (en) 2022-07-13
IL290056B1 (en) 2026-04-01
RS67632B1 (sr) 2026-02-27
JP7767264B2 (ja) 2025-11-11
EP4025192C0 (en) 2025-12-03
JP2022545862A (ja) 2022-11-01
US20220409701A1 (en) 2022-12-29
EP4025192B1 (en) 2025-12-03
CN114340655A (zh) 2022-04-12

Similar Documents

Publication Publication Date Title
PL4025192T3 (pl) Sposób wytwarzania tabletki zawierającej peptydy glp-1
IL279827A (en) Gip/glp1 co-agonist compounds
IL283385A (en) Modified gip peptide analogues
SG11202100112YA (en) Methods of using a gip/glp1 co-agonist for therapy
IL261845B (en) Method for preparing glucagon-like peptides
IL280159A (en) Method of using a gip/glp1 co-agonist for diabetes
IL276067A (en) Production of glucagon peptides
PL3709979T3 (pl) Sposób wytwarzania powlekanej kapsułki twardej
PL3774862T3 (pl) Nowe analogi glp-1
IL290447A (en) Pharmaeutical composition comprising ensifentrine
EP4493138A4 (en) INGESTED CAPSULES
EP3795118A4 (en) NASAL IMPLANT MANUFACTURING PROCESS
PL4046129T3 (pl) Sposób wytwarzania
PL3942107T3 (pl) Sposób wytwarzania
PL4076015T3 (pl) Sposób wytwarzania arkusza materiału zawierającego alkaloidy
GB2582844B (en) Method of assembling a structure
HUE060159T2 (hu) A lazacikra elõállítására vonatkozó akvakultúra-eljárás
IL289634A (en) Novel reprogramming method
PL3965739T3 (pl) Postacie dawkowane będące tabletkami oleilofosfocholiny
EP3749779A4 (en) Library preparation
DK4029059T3 (da) Fremstillingsfremgangsmåde
DK3808666T3 (da) Fremgangsmåde til fremstilling af et pakket legeme
GB201812691D0 (en) Method of forming a structure upon a substrate
PL4069912T3 (pl) Sposób wytwarzania systemu konstrukcyjnego
GB2585451B (en) Method of manufacturing a structure